(Q81251723)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470907%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Complete remission sustained 3 years from treatment initiation is a powerful surrogate for extended survival in multiple myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470907%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

Bart Barlogie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470907%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Elias Anaissie

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470907%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Jeffrey Haessler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470907%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Fritz van Rhee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470907%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Mauricio Pineda-Roman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470907%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Klaus Hollmig

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470907%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Yazan Alsayed

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470907%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Joshua Epstein

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470907%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

John D Shaughnessy

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470907%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

John Crowley

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470907%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470907%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

number of pages

5

1 reference

inferred from page(s)

published in

Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470907%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470907%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470907%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

355-359

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470907%20AND%20SRC:MED&resulttype=core&format=json

High-dose intravenous melphalan for plasma-cell leukaemia and myeloma

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23546

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23546

7 January 2021

Single versus double autologous stem-cell transplantation for multiple myeloma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23546

7 January 2021

Complete response in myeloma extends survival without, but not with history of prior monoclonal gammopathy of undetermined significance or smouldering disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23546

7 January 2021

Benefit of complete response in multiple myeloma limited to high-risk subgroup identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23546

7 January 2021

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23546

7 January 2021

Testing standard and genetic parameters in 220 patients with multiple myeloma with complete data sets: superiority of molecular genetics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23546

7 January 2021

Thalidomide and hematopoietic-cell transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23546

7 January 2021

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23546

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23546

7 January 2021

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23546

7 January 2021

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23546

7 January 2021

Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23546

7 January 2021

High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23546

7 January 2021

Identifiers

DOI

10.1002/CNCR.23546

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470907%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference